Status:
COMPLETED
Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Bladder Cancer
Entire Ileal Conduit
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The process of enhancing the functional capacity of an individual before an operation to enable him or her to withstand the stress of surgery has been termed prehabilitation. It has been shown that po...
Detailed Description
Study Arms 1. Standard group Patients in this group will follow standard MUHC clinical guidelines. This group will receive general instructions on exercises (breathing, ankle rotation) to be done bef...
Eligibility Criteria
Inclusion
- Aged 18 and older
- Referred electively for radical resection of a bladder tumor (may or may not receive adjuvant therapy).
Exclusion
- American Society of Anesthesiologists (ASA) health status class 4-5 or co-morbid medical, physical and mental conditions (e.g. dementia, disabling orthopedic and neuromuscular disease, psychosis)
- Severe cardiac abnormalities
- Severe end-stage organ disease such as cardiac failure (New York Heart Association classes I-IV)
- Chronic Obstructive Pulmonary Disease (COPD)
- Hepatic failure (liver enzymes \>50% over the normal range)
- Sepsis
- Morbid obesity (BMI \>35)
- Anemia (hematocrit \< 30 %, haemoglobin \<100 g/L, albumin \< 25 g/L)
- Poor comprehension of English or French.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01836978
Start Date
June 1 2013
End Date
December 1 2017
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3A 1A1